Description

AVIL 50 MG

Indications

AVIL 50 MG, containing the active ingredient Pheniramine maleate, is primarily indicated for the relief of allergic symptoms such as rhinitis, urticaria, and conjunctivitis. It is also used in the management of motion sickness and as a sedative for short-term treatment of insomnia. AVIL is effective in alleviating symptoms associated with allergic reactions, such as sneezing, itching, and runny nose, making it a valuable option for patients suffering from seasonal allergies or allergic reactions to environmental factors.

Mechanism of Action

AVIL 50 MG functions as an antihistamine by blocking the action of histamine at the H1 receptor sites. Histamine is a chemical released during allergic reactions that contributes to symptoms such as itching, swelling, and vasodilation. By inhibiting the binding of histamine to its receptors, AVIL reduces the physiological effects associated with allergic responses. Additionally, AVIL has anticholinergic properties, which may contribute to its effectiveness in treating motion sickness and its sedative effects.

Pharmacological Properties

Pheniramine maleate, the active ingredient in AVIL, is a first-generation antihistamine. It is well-absorbed from the gastrointestinal tract, with peak plasma concentrations typically occurring within 1 to 2 hours after oral administration. The drug is metabolized in the liver and has a half-life of approximately 12 to 15 hours, allowing for once or twice daily dosing in most cases. AVIL is excreted primarily in the urine, and its pharmacokinetic profile supports its use in both acute and chronic allergic conditions.

Contraindications

AVIL 50 MG is contraindicated in patients with known hypersensitivity to pheniramine or any of the excipients in the formulation. It should not be used in individuals with severe asthma, narrow-angle glaucoma, or prostatic hypertrophy, as the anticholinergic effects may exacerbate these conditions. Additionally, AVIL is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing such treatment due to the risk of hypertensive crisis.

Side Effects

Common side effects associated with AVIL 50 MG include drowsiness, dizziness, dry mouth, blurred vision, and constipation. These effects are primarily due to its antihistaminic and anticholinergic properties. In some cases, patients may experience paradoxical stimulation, particularly in children. Rare but serious side effects may include allergic reactions, such as rash, itching, or swelling, and cardiovascular effects such as palpitations. Patients should be advised to report any unusual or severe side effects to their healthcare provider.

Dosage and Administration

The recommended dosage of AVIL 50 MG varies depending on the condition being treated. For adults and children over 12 years, the typical dose is 25 to 50 mg taken orally every 4 to 6 hours, not exceeding 150 mg per day. For children aged 6 to 12 years, the recommended dose is 12.5 to 25 mg every 4 to 6 hours, with a maximum of 75 mg per day. It is important to follow the prescribing physician’s guidance and to use the lowest effective dose for the shortest duration necessary to manage symptoms.

Interactions

AVIL 50 MG may interact with several medications, leading to increased side effects or altered therapeutic effects. Concurrent use with other central nervous system depressants, such as alcohol, benzodiazepines, or opioids, may enhance sedation and respiratory depression. Additionally, the use of AVIL with other antihistamines or anticholinergic drugs may exacerbate side effects. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions.

Precautions

Patients taking AVIL 50 MG should be cautioned about the potential for drowsiness and impaired coordination, particularly when driving or operating heavy machinery. Special precautions should be taken in elderly patients, who may be more susceptible to the sedative effects and anticholinergic side effects of the medication. Patients with pre-existing conditions such as cardiovascular disease, hypertension, or urinary retention should use AVIL with caution. It is also advisable to consult a healthcare provider before using AVIL during pregnancy or breastfeeding.

Clinical Studies

Clinical studies have demonstrated the efficacy of AVIL 50 MG in treating allergic rhinitis and other allergic conditions. In randomized controlled trials, patients receiving pheniramine reported significant improvement in symptoms compared to placebo. Studies have also indicated that AVIL is effective in managing motion sickness, with patients experiencing reduced nausea and vomiting. However, due to the variability in individual responses, it is essential for healthcare providers to assess the appropriateness of AVIL for each patient based on their specific clinical situation.

Conclusion

AVIL 50 MG is a well-established antihistamine that provides effective relief from allergic symptoms and is useful in the management of motion sickness. Its mechanism of action involves blocking histamine receptors, which alleviates the physiological effects of allergic reactions. While generally well-tolerated, AVIL can cause side effects, and its use should be carefully monitored, especially in vulnerable populations. As with any medication, it is crucial for patients to follow dosing instructions and consult healthcare providers regarding any concerns or potential interactions with other medications.